{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:45:40Z","timestamp":1759495540022},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T00:00:00Z","timestamp":1353715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10616-012-9516-4","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T08:50:36Z","timestamp":1353660636000},"page":"621-628","source":"Crossref","is-referenced-by-count":9,"title":["Genotoxicity of pemetrexed in human peripheral blood lymphocytes"],"prefix":"10.1007","volume":"65","author":[{"given":"Erman Salih","family":"\u0130stifli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Topakta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,24]]},"reference":[{"key":"9516_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1383-5742(00)00049-1","volume":"463","author":"RJ Albertini","year":"2000","unstructured":"Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111\u2013172","journal-title":"Mutat Res"},{"key":"9516_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0027-5107(69)90016-5","volume":"8","author":"MA Bender","year":"1969","unstructured":"Bender MA, Brewen JG (1969) Factors influencing chromosome aberration yields in the human peripheral leukocyte system. Mutat Res 8:383\u2013399","journal-title":"Mutat Res"},{"key":"9516_CR3","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"BC Blount","year":"1997","unstructured":"Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci 94:3290\u20133295","journal-title":"Proc Natl Acad Sci"},{"key":"9516_CR4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1535-7163.MCT-06-0343","volume":"6","author":"S Chattopadhyay","year":"2007","unstructured":"Chattopadhyay S, Moran RG, Goldman ID (2007) Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther 6:404\u2013417","journal-title":"Mol Cancer Ther"},{"key":"9516_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1382-6689(00)00041-7","volume":"8","author":"R Choudhury","year":"2000","unstructured":"Choudhury R, Ghosh SK, Palo AK (2000) Cytogenetic toxicity of methotrexate in mouse bone marrow. Environ Toxicol Pharmacol 8:191\u2013196","journal-title":"Environ Toxicol Pharmacol"},{"key":"9516_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1382-6689(01)00073-4","volume":"10","author":"R Choudhury","year":"2001","unstructured":"Choudhury R, Ghosh SK, Palo AK (2001) Potential transmission of the cytogenetic toxic effects of methotrexate in the male germline cells of Swiss mice. Environ Toxicol Pharmacol 10:81\u201388","journal-title":"Environ Toxicol Pharmacol"},{"key":"9516_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1383-5718(98)00025-4","volume":"413","author":"M Chow","year":"1998","unstructured":"Chow M, Koo J, Ng P, Rubin H (1998) Random population-wide genetic damage induced in replicating cells treated with methotrexate. Mutat Res 413:251\u2013264","journal-title":"Mutat Res"},{"key":"9516_CR8","doi-asserted-by":"crossref","first-page":"e10031","DOI":"10.1371\/journal.pone.0010031","volume":"5","author":"E Dalkic","year":"2010","unstructured":"Dalkic E, Wang X, Wright N, Chan C (2010) Cancer-drug associations: a complex system. PLoS ONE 5:e10031","journal-title":"PLoS ONE"},{"key":"9516_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-444-80519-5.50023-7","volume-title":"Handbook of mutagenicity test procedures","author":"HJ Evans","year":"1984","unstructured":"Evans HJ (1984) Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In: Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures, 2nd edn. Elsevier, Amsterdam, pp 405\u2013427","edition":"2"},{"key":"9516_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","volume":"455","author":"M Fenech","year":"2000","unstructured":"Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81\u201395","journal-title":"Mutat Res"},{"key":"9516_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0027-5107(73)90024-9","volume":"18","author":"WN Hittelman","year":"1973","unstructured":"Hittelman WN (1973) The type and time of occurrence of aminopterin-induced chromosome aberrations in cultured potorous cells. Mutat Res 18:93\u2013102","journal-title":"Mutat Res"},{"key":"9516_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0165-1161(79)90126-2","volume":"64","author":"MK Jensen","year":"1979","unstructured":"Jensen MK, Nyfors A (1979) Cytogenetic effects of methotrexate on human cells in vivo: comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by the micronucleus test. Mutat Res 64:339\u2013343","journal-title":"Mutat Res"},{"key":"9516_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/138945010790031072","volume":"11","author":"SCH Kao","year":"2010","unstructured":"Kao SCH, Phan VH, Clarke SJ (2010) Predictive markers for haematological toxicity of pemetrexed. Curr Drug Targets 11:48\u201357","journal-title":"Curr Drug Targets"},{"key":"9516_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-1218(92)90225-O","volume":"278","author":"Y Kasahara","year":"1992","unstructured":"Kasahara Y, Nakai Y, Miura D, Yagi K, Hirabayashi K, Makita T (1992a) Mechanism of induction of micronuclei and chromosome aberrations in mouse bone marrow by multiple treatments of methotrexate. Mutat Res 278:145\u2013151","journal-title":"Mutat Res"},{"key":"9516_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-1218(92)90007-M","volume":"280","author":"Y Kasahara","year":"1992","unstructured":"Kasahara Y, Wakata A, Nakai Y, Yuno K, Miura D, Yagi K, Hirabayashi K, Makita T (1992b) The micronucleus test using peripheral blood reticulocytes from methotrexate-treated mice. Mutat Res 280:117\u2013128","journal-title":"Mutat Res"},{"key":"9516_CR16","first-page":"5045","volume":"48","author":"KT Kelsey","year":"1988","unstructured":"Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR, Little JB (1988) Persistently elevated sister chromatid exchanges in ethylene oxide-exposed primates: the role of a subpopulation of high frequency cells. Cancer Res 48:5045\u20135050","journal-title":"Cancer Res"},{"key":"9516_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1520-6866(1997)17:6<313::AID-TCM2>3.0.CO;2-K","volume":"17","author":"C Keshava","year":"1997","unstructured":"Keshava C, Keshava N, Whong WZ, Nath J, Ong TM (1997) Inhibition of methotrexate-induced chromosomal damage by vanillin and chlorophyllin in V79 cells. Teratog Carcinog Mutagen 17:313\u2013326","journal-title":"Teratog Carcinog Mutagen"},{"key":"9516_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mrgentox.2003.07.005","volume":"540","author":"M Kirsch-Volders","year":"2003","unstructured":"Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Lorge E, Norppa H, Surrall\u00e9s J, von der Hude W, Wakata A (2003) Report from the in vitro micronucleus assay working group. Mutat Res 540:153\u2013163","journal-title":"Mutat Res"},{"key":"9516_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0027-5107(77)90046-X","volume":"5","author":"EA Lezana","year":"1977","unstructured":"Lezana EA, Bianchi NO, Bianchi MS, Zabala-Suarez JE (1977) Sister chromatid exchanges in down syndromes and normal human beings. Mutat Res 5:85\u201390","journal-title":"Mutat Res"},{"key":"9516_CR20","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.81.18.5694","volume":"81","author":"JC Li","year":"1984","unstructured":"Li JC, Kaminskas E (1984) Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc Natl Acad Sci 81:5694\u20135698","journal-title":"Proc Natl Acad Sci"},{"key":"9516_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0027-5107(78)90141-0","volume":"52","author":"ML Mace","year":"1978","unstructured":"Mace ML, Daskal Y, Wray W (1978) Scanning electron microscopy of chromosome aberrations. Mutat Res 52:199\u2013206","journal-title":"Mutat Res"},{"key":"9516_CR22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1289\/ehp.021101077","volume":"110","author":"C Paz-y-Mi\u00f1o","year":"2002","unstructured":"Paz-y-Mi\u00f1o C, Bustamante G, S\u00e1nchez ME, Leone PE (2002) Cytogenetic monitoring in a population occupationally exposed to pesticide in Ecuador. Environ Health Persp 110:1077\u20131080","journal-title":"Environ Health Persp"},{"key":"9516_CR23","first-page":"459","volume-title":"Handbook of mutagenicity test procedures","author":"PE Perry","year":"1984","unstructured":"Perry PE, Thomson EJ (1984) The methodology of sister chromatid exchanges. In: Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures, 2nd edn. Elsevier, Amsterdam, pp 459\u2013529","edition":"2"},{"key":"9516_CR24","first-page":"4441","volume":"41","author":"RG Poser","year":"1981","unstructured":"Poser RG, Sirotnak FM, Chello PL (1981) Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. Cancer Res 41:4441\u20134446","journal-title":"Cancer Res"},{"key":"9516_CR25","first-page":"390","volume":"60","author":"A Rothfuss","year":"2000","unstructured":"Rothfuss A, Sch\u00fctz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390\u2013394","journal-title":"Cancer Res"},{"key":"9516_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-2571(97)00017-4","volume":"38","author":"C Shih","year":"1998","unstructured":"Shih C, Habeck LL, Mendelsohn LG, Chen VJ, Schultz RM (1998) Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA). Advan Enzyme Regul 38:135\u2013152","journal-title":"Advan Enzyme Regul"},{"key":"9516_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/annonc\/mdg099","volume":"14","author":"EF Smit","year":"2003","unstructured":"Smit EF, Mattson K, von Pawel J, Manegold C, Clarke S, Postmus PE (2003) ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study. Ann Oncol 14:455\u2013460","journal-title":"Ann Oncol"},{"key":"9516_CR28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00273070","volume":"70","author":"G Speit","year":"1985","unstructured":"Speit G, Haupter S (1985) On the mechanisms of differential giemsa staining of bromodeoxyuridine-substituted chromosomes. II. Differences between the demonstration of sister chromatid differentiation and replication patterns. Hum Genet 70:126\u2013129","journal-title":"Hum Genet"},{"key":"9516_CR29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002800050608","volume":"39","author":"JL Tonkinson","year":"1997","unstructured":"Tonkinson JL, Marder P, Andis SL, Schultz RM, Gossett LS, Shih C, Mendelsohn LG (1997) Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis. Cancer Chemoth Pharm 39:521\u2013531","journal-title":"Cancer Chemoth Pharm"},{"key":"9516_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mrgentox.2006.10.006","volume":"627","author":"DJ Tweats","year":"2007","unstructured":"Tweats DJ, Blakey D, Heflich RH, Jacobs A, Jacobsen SD, Morita T, Nohmi T, O\u2019Donovan MR, Sasaki YF, Sofuni T, Tice R (2007) Report of the IWGT working group on strategy\/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutat Res 627:92\u2013105","journal-title":"Mutat Res"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-012-9516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10616-012-9516-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-012-9516-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:29:25Z","timestamp":1559244565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10616-012-9516-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9516"],"URL":"https:\/\/doi.org\/10.1007\/s10616-012-9516-4","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,24]]}}}